K
Kathleen O. Stewart
Researcher at Harvard University
Publications - 14
Citations - 374
Kathleen O. Stewart is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Inflammatory bowel disease. The author has an hindex of 8, co-authored 9 publications receiving 304 citations. Previous affiliations of Kathleen O. Stewart include University of Rochester & Dartmouth–Hitchcock Medical Center.
Papers
More filters
Journal ArticleDOI
The Influence of Hydrogen Bonding Side-Groups on Viscoelastic Behavior of Linear and Network Polymers
TL;DR: In this paper, the authors investigate how dynamic behavior of functional poly(n-butyl acrylate) melts and cross-linked networks is influenced by different hydrogen-bonding side groups.
Journal ArticleDOI
Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease
Patricia L. Pringle,Kathleen O. Stewart,Joanna M. Peloquin,Holly C. Sturgeon,Deanna D. Nguyen,Jenny Sauk,John J. Garber,Vijay Yajnik,Ashwin N. Ananthakrishnan,Andrew T. Chan,Andrew T. Chan,Ramnik J. Xavier,Ramnik J. Xavier,Hamed Khalili +13 more
TL;DR: The data suggest that obesity does not negatively impact long-term progression of CD, even after accounting for genetic predisposition.
Journal ArticleDOI
Identification and characterization of a novel association between dietary potassium and risk of Crohn's disease and ulcerative colitis
Hamed Khalili,Sakshi Malik,Ashwin N. Ananthakrishnan,John J. Garber,Leslie M. Higuchi,Amit Joshi,Joanna M. Peloquin,James M. Richter,Kathleen O. Stewart,Gary C. Curhan,Amit Awasthi,Vijay Yajnik,Andrew T. Chan,Andrew T. Chan +13 more
TL;DR: Dietary potassium is inversely associated with risk of CD with both in vitro and gene–environment interaction data suggesting a potential role for potassium in regulating immune tolerance through its effect on Tregs and TH17 pathway.
Journal ArticleDOI
ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial
David A. Drew,Samantha M. Chin,Katherine K. Gilpin,Melanie P. Parziale,Emily N. Pond,Madeline M. Schuck,Kathleen O. Stewart,Meaghan Flagg,Crystal A. Rawlings,Vadim Backman,Peter J. Carolan,Daniel C. Chung,Francis Colizzo,Matthew L. Freedman,Manish Gala,John J. Garber,Curtis Huttenhower,Dmitriy Kedrin,Hamed Khalili,Douglas S. Kwon,Sanford D. Markowitz,Ginger L. Milne,Norman S. Nishioka,James M. Richter,Hemant K. Roy,Kyle Staller,Molin Wang,Molin Wang,Andrew T. Chan +28 more
TL;DR: Aspirin may prevent colorectal cancer through multiple, interrelated mechanisms and the ASPIRED trial will scrutinize these pathways and investigate putative mechanistically based risk-stratification biomarkers.
Journal ArticleDOI
Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis
Dora Colussi,Behzad Salari,Kathleen O. Stewart,Gregory Y. Lauwers,James R Richter,Andrew T. Chan,Luigi Ricciardiello,Hamed Khalili +7 more
TL;DR: Despite differences in the clinical characteristics, response rates to available treatments appeared to be similar in both LC and CC and older patients may have a better response to bismuth subsalicylate therapy.